Protagonist Therapeutics Announces U.S. FDA Approval of ICOTYDE(TM) (icotrokinra) for the Treatment of Moderate to Severe Plaque Psoriasisaccessnewswire.com
NAPC Defense, Inc. Positioned as Primary Subcontractor on Obera Portfolio Following Asset Acquisition by Native American Pride Constructors, LLCglobenewswire.com
Blue Lagoon's Milling Partner has Processed 3,000 Tonnes of Dome Mountain Material Producing Over 210 Tonnes of Gold & Silver Concentratethenewswire.com
PDD Holdings to Report Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results on March 25, 2026globenewswire.com
Akari Therapeutics Announces Abstract Accepted for Poster Presentation at the American Association for Cancer Research Annual Meeting 2026globenewswire.com
Gilat Defense, AWS, SES Space & Defense and WAVE Consortium Demonstrate Virtualized SATCOM Gateway Modem Architecture at Satellite 2026globenewswire.com
Transpetro expands shipping clients beyond Petrobras, signs deals with Trafigura, Ipirangareuters.com
60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (NDIN) with FDA for Australian Chestnut Extractglobenewswire.com